ARTICLE | Company News
Sequenom, Morphochem in discovery deal
June 7, 2001 7:00 AM UTC
Morphochem (Munich, Germany) will use its chemical genomics platform to validate cancer and Type II diabetes gene targets identified by SQNM's MassArray screening technology. The companies will jointl...